Support PenkePTC Therapeutics Inc - Trending symbols
Latest News of PTC Therapeutics Inc
| Date | Title | Read |
|---|---|---|
| 2025-04-25 15:00 | PTC Therapeutics Receives Positive CHMP Opinion for Sephience™ (sepiapterin) for the Treatment of Children and Adults Living with Phenylketonuria (PKU) | Read |
Notifications
| Type | Notification | Date |
|---|---|---|
| RSI Oversold | Oversold RSI (Relative Strength Index) | 2025-05-07 |
Trends
| 2023-12-31 | 2024-03-31 | 2024-06-30 | 2024-09-30 | 2024-12-31 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Total Other Income Expense Net | -160,171 | 121,028 | -39,143 | -6,372 | -45,515 | 2,034 | -43,481 | 111,171 | 67,690 | |
| Net Debt | -178,975 | 52,063 | -126,912 | -132,363 | -259,275 | 133,479 | -125,796 | 1,817,159 | 1,691,363 | |
| EBIT | -160,657 | 45,442 | -115,215 | -3,949 | -119,164 | -57,649 | -176,813 | 179,933 | 3,120 | |
| EBITDA | -89,746 | 23,902 | -65,844 | -2,315 | -68,159 | -50,005 | -118,164 | 201,989 | 83,825 | |
| Operating Income | -160,657 | 45,442 | -115,215 | -94,328 | -209,543 | 91,379 | -118,164 | 121,284 | 3,120 | |
| Interest Expense | 20,880 | 3,620 | 24,500 | 2,831 | 27,331 | 2,084 | 29,415 | -57,575 | -28,160 | |
| Net Invested Capital | 250,150 | -194,305 | 55,845 | 168,791 | 224,636 | -110,106 | 114,530 | -121,155 | -6,625 | |
| Net non Operating Income Other | -31,379 | 19,524 | -11,855 | -22,502 | -34,357 | -3,784 | -38,141 | 73,287 | 35,146 | |
| Accumulated Other Comprehensive Income | -46,087 | 13,126 | -32,961 | 8,679 | -24,282 | 5,674 | -18,608 | 28,859 | 10,251 | |
| Total Stockholder Equity | 292,576 | -95,999 | 196,577 | -91,651 | 104,926 | -103,488 | 1,438 | -92,019 | -90,581 | |
| Other Stockholders Equity | 2,033,972 | 29,715 | 2,063,687 | 28,847 | 2,092,534 | 31,072 | 2,123,606 | -2,142,214 | -18,608 |
Comments
How you think about this?